0,955  0,004  Apoptosis agonist
0,947  0,005  Antiinflammatory
0,938  0,004  Transcription factor NF kappa B inhibitor
0,929  0,003  Chemopreventive
0,906  0,003  Caspase 9 stimulant
0,870  0,005  Antineoplastic (lung cancer)
0,858  0,004  Nitric oxide antagonist
0,848  0,001  Phosphorylase inhibitor
0,836  0,006  Antineoplastic (breast cancer)
0,813  0,004  Hepatic disorders treatment
0,808  0,005  Antileukemic
0,806  0,005  Antineoplastic (melanoma)
0,794  0,003  Hepatoprotectant
0,787  0,005  Antineoplastic (ovarian cancer)
0,789  0,009  TNF expression inhibitor
0,773  0,008  Antidiabetic
0,773  0,008  Cyclophilin D inhibitor
0,766  0,005  Prostate cancer treatment
0,751  0,004  Antineoplastic (pancreatic cancer)
0,744  0,001  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,741  0,008  Chemoprotective
0,737  0,004  Apoptosis antagonist
0,734  0,002  AMP-activated protein kinase stimulant
0,735  0,003  Antineoplastic (endocrine cancer)
0,733  0,002  Phospholipase C inhibitor
0,724  0,003  Protein-tyrosine phosphatase 1B inhibitor
0,718  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,690  0,004  Protein-tyrosine phosphatase inhibitor
0,697  0,014  Antineoplastic (colorectal cancer)
0,681  0,003  Insulin sensitizer
0,679  0,005  Antineoplastic (multiple myeloma)
0,680  0,006  Caspase 3 stimulant
0,675  0,003  ICAM1 expression inhibitor
0,686  0,014  Antineoplastic (colon cancer)
0,668  0,001  Interferon gamma antagonist
0,660  0,004  Insulin secretagoues
0,645  0,004  Antihypoxic
0,628  0,007  Hypoglycemic
0,629  0,009  AR expression inhibitor
0,633  0,012  Vasodilator, peripheral
0,656  0,042  Alpha-glucosidase inhibitor
0,608  0,005  Antihypertriglyceridemic
0,608  0,011  Antioxidant
0,608  0,013  Antineoplastic (cervical cancer)
0,598  0,005  Vascular (periferal) disease treatment
0,600  0,010  Antidiabetic (type 2)
0,602  0,016  Immunostimulant
0,592  0,012  Cytotoxic
0,585  0,005  Wound healing agent
0,582  0,010  Antineoplastic (glioma)
0,580  0,012  NOS2 expression inhibitor
0,579  0,017  5 Hydroxytryptamine release stimulant
0,573  0,022  Cholesterol antagonist
0,558  0,011  Antipyretic
0,546  0,004  Antiviral (Influenza)
0,543  0,004  Antiviral (Influenza A)
0,553  0,015  Cardioprotectant
0,539  0,002  Contraceptive female
0,549  0,022  Antithrombotic
0,531  0,006  Diuretic
0,533  0,010  Antineoplastic (glioblastoma multiforme)
0,539  0,019  Sensitization
0,521  0,017  NOS3 expression inhibitor
0,509  0,018  Antineoplastic (brain cancer)
0,505  0,026  Bone diseases treatment
0,495  0,021  Lipoprotein disorders treatment
0,485  0,011  Antineoplastic (renal cancer)
0,486  0,016  Cardiodepressant
0,478  0,010  Antineoplastic (lymphocytic leukemia)
0,469  0,010  UGT1A4 substrate
0,472  0,015  UGT2B4 substrate
0,487  0,037  Immunosuppressant
0,452  0,009  Contraceptive
0,446  0,003  Cholesterol synthesis inhibitor
0,443  0,003  Inducible nitric-oxide synthase inhibitor
0,442  0,005  Antiviral (Hepatitis B)
0,442  0,006  Lipocortins synthesis antagonist
0,449  0,015  Antineoplastic (liver cancer)
0,442  0,008  Antiviral (Hepatitis)
0,442  0,011  Antiviral (HIV)
0,437  0,009  Sodium/bile acid cotransporter inhibitor
0,443  0,016  UDP-glucuronosyltransferase substrate
0,452  0,027  Antiosteoporotic
0,464  0,044  Antipruritic, allergic
0,444  0,027  Metabolic disease treatment
0,449  0,034  Antihypercholesterolemic
0,431  0,022  Tumour necrosis factor alpha release inhibitor
0,413  0,004  Gastrin inhibitor
0,421  0,013  Growth hormone agonist
0,408  0,005  Acute respiratory distress syndrome (ARDS) treatment
0,411  0,010  Platelet adhesion inhibitor
0,407  0,012  Skin whitener
0,402  0,008  Liver fibrosis treatment
0,394  0,004  Cyclooxygenase 3 inhibitor
0,399  0,011  Prostate disorders treatment
0,416  0,031  Carcinogenic
0,434  0,051  Atherosclerosis treatment
0,406  0,026  Renal disease treatment
0,389  0,015  Antiviral (Herpes)
0,380  0,013  UGT2B7 substrate
0,368  0,003  Transcription factor NF kappa B stimulant
0,388  0,024  Angiogenesis stimulant
0,380  0,023  Antiulcerative
0,381  0,029  Hypolipemic
0,385  0,033  Antiprotozoal (Leishmania)
0,363  0,012  Lipid peroxidase inhibitor
0,350  0,006  Expectorant
0,424  0,081  Antiarthritic
0,371  0,028  Vasodilator
0,353  0,015  Antiacne
0,370  0,034  Proliferative diseases treatment
0,359  0,023  Abortion inducer
0,370  0,039  Antineoplastic (non-small cell lung cancer)
0,343  0,014  Hair growth stimulant
0,359  0,033  Myocardial infarction treatment
0,357  0,030  Transcription factor STAT3 inhibitor
0,325  0,012  Antiviral (Hepatitis C)
0,362  0,053  Antipsoriatic
0,323  0,018  Antineoplastic (squamous cell carcinoma)
0,324  0,019  Prostatic (benign) hyperplasia treatment
0,381  0,086  Antibacterial
0,314  0,029  UGT1A1 substrate
0,305  0,021  Melanin inhibitor
0,344  0,062  Antifungal
0,291  0,023  Antineoplastic (carcinoma)
0,286  0,019  Protein kinase stimulant
0,281  0,018  Interleukin 6 antagonist
0,308  0,050  Free radical scavenger
0,272  0,015  UGT2B9 substrate
0,264  0,006  HDL-cholesterol increasing
0,313  0,065  Interleukin 2 agonist
0,262  0,020  Phospholipase A2 inhibitor
0,286  0,048  Antineoplastic (sarcoma)
0,284  0,049  UGT1A6 substrate
0,255  0,026  UGT2B15 substrate
0,254  0,028  Diabetic nephropathy treatment
0,238  0,013  Antinephritic
0,230  0,015  Antihemorrhagic
0,301  0,087  Vasodilator, coronary
0,254  0,040  P-glycoprotein inhibitor
0,271  0,060  Antiglaucomic
0,242  0,034  Antihelmintic (Nematodes)
0,228  0,021  UGT2B10 substrate
0,208  0,003  Diacylglycerol O-acyltransferase inhibitor
0,223  0,020  Antitussive
0,208  0,005  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,214  0,021  Arachidonic acid antagonist
0,227  0,037  Antineoplastic (gastric cancer)
0,260  0,073  Teratogen
0,187  0,002  Heme oxygenase stimulant
0,266  0,082  CYP2C19 substrate
0,227  0,045  Antipruritic, non-allergic
0,185  0,006  Anabolic
0,191  0,015  Antiinfertility, female
0,192  0,018  Adenylate cyclase stimulant
0,241  0,070  Antineoplastic (lymphoma)
0,254  0,084  Transcription factor STAT inhibitor
0,199  0,028  DNA polymerase I inhibitor
0,175  0,006  5-Alpha-reductase inhibitor
0,186  0,018  Protease inhibitor
0,224  0,056  Antihelmintic
0,194  0,028  Gout treatment
0,169  0,008  CC chemokine 6 receptor antagonist
0,164  0,004  Na+ K+ transporting ATPase inhibitor
0,168  0,008  Antiviral (Rhinovirus)
0,164  0,005  Aldosterone antagonist
0,289  0,130  Histamine release inhibitor
0,215  0,060  Non-steroidal antiinflammatory agent
0,271  0,117  CYP3A4 substrate
0,163  0,014  Antiprotozoal (Toxoplasma)
0,167  0,019  Beta glucuronidase inhibitor
0,164  0,018  Nitric-oxide synthase inhibitor
0,173  0,033  Farnesoid X receptor antagonist
0,217  0,077  Antiparasitic
0,150  0,011  Lanosterol 14 alpha demethylase inhibitor
0,167  0,030  Growth stimulant
0,149  0,016  UGT2B11 substrate
0,142  0,009  Glycine receptor antagonist
0,189  0,057  Thrombolytic
0,214  0,086  Embryotoxic
0,240  0,112  Analeptic
0,155  0,030  Antineoplastic antibiotic
0,158  0,035  Beta amyloid protein antagonist
0,139  0,017  Contraceptive male
0,204  0,082  Antineoplastic enhancer
0,163  0,042  Monophenol monooxygenase inhibitor
0,152  0,032  Choleretic
0,262  0,145  Antiobesity
0,118  0,003  Cholesterol ester transfer protein antagonist
0,152  0,039  Interleukin 1b antagonist
0,118  0,008  CD45 antagonist
0,142  0,034  Anticataract
0,197  0,090  Fibrosis treatment
0,114  0,011  Androgen agonist
0,128  0,025  ABCA1 expression enhancer
0,107  0,004  Lipocortins synthesis agonist
0,121  0,019  Bile acid receptor antagonist
0,220  0,118  Respiratory analeptic
0,210  0,110  Cardiotonic
0,105  0,006  Nitric oxide donor
0,183  0,089  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,136  0,044  Alcohol dehydrogenase substrate
0,182  0,095  Neurotrophic factor enhancer
0,093  0,007  RNA-directed RNA polymerase stimulant
0,122  0,038  Antiviral (SARS coronavirus)
0,122  0,038  Antiviral (Coronavirus)
0,272  0,193  Alzheimer's disease treatment
0,138  0,059  Antihyperlipoproteinemic
0,114  0,037  Androgen antagonist
0,095  0,018  CDC25B inhibitor
0,128  0,052  Microtubule formation inhibitor
0,115  0,041  Uric acid excretion stimulant
0,094  0,021  Anticholelithogenic
0,110  0,038  Actinic keratosis treatment
0,164  0,095  Antirickettsial
0,096  0,030  Histone deacetylase stimulant
0,096  0,030  Histone deacetylase SIRT1 stimulant
0,084  0,019  Transcription factor AP-1 inhibitor
0,072  0,007  Farnesoid X receptor agonist
0,196  0,133  UGT1A9 substrate
0,078  0,015  Postcoital contraceptive
0,132  0,069  Liver cirrhosis treatment
0,111  0,051  Chronic obstructive bronchitis treatment
0,157  0,101  LDLR expression enhancer
0,108  0,055  Sulfotransferase substrate
0,137  0,085  Antidiabetic (type 1)
0,050  0,001  Telomerase stimulant
0,146  0,099  Antipruritic
0,091  0,044  3C-Like protease (SARS coronavirus) inhibitor
0,071  0,026  Estrogen agonist
0,138  0,093  UGT1A3 substrate
0,084  0,039  Lipase inhibitor
0,049  0,005  Glucocorticoid agonist
0,051  0,008  Tubulin agonist
0,046  0,003  Corticosteroid-like
0,058  0,017  Microtubule stabilization
0,047  0,008  Estrone sulfatase inhibitor
0,118  0,080  Acetylcholinesterase inhibitor
0,053  0,014  Glucocorticoid antagonist
0,050  0,012  Glucose-6-phosphate dehydrogenase inhibitor
0,078  0,042  Glycine receptor agonist
0,062  0,027  Acetyl-CoA transferase 2 inhibitor
0,071  0,042  SULT2A1 substrate
0,057  0,028  Glucose-6-phosphate translocase inhibitor
0,087  0,059  Ornithine decarboxylase inhibitor
0,099  0,071  Topoisomerase I inhibitor
0,107  0,081  Estrogen antagonist
0,052  0,026  Cholesterol esterase inhibitor
0,064  0,039  Aromatase inhibitor
0,089  0,064  Thioredoxin inhibitor
0,049  0,026  Neuraminidase (Influenza A) inhibitor
0,056  0,033  Acetyl-CoA transferase inhibitor
0,209  0,186  CYP2C9 substrate
0,037  0,019  HMG CoA reductase inhibitor
0,041  0,024  Retinoic acid alpha receptor agonist
0,042  0,028  Liver X receptor alpha agonist
0,065  0,051  Potassium channel large-conductance Ca-activated activator
0,070  0,057  CDC25A inhibitor
0,093  0,082  UGT2B1 substrate
0,029  0,018  1,3-Beta-glucan synthase inhibitor
0,025  0,014  Retinoid X gamma receptor agonist
0,084  0,074  SULT1E1 substrate
0,023  0,014  Retinoic acid gamma receptor agonist
0,051  0,042  Postmenopausal disorders treatment
0,179  0,171  Antineoplastic (bladder cancer)
0,027  0,019  Hedgehog signaling activator
0,027  0,019  Retinoid X gamma receptor antagonist
0,085  0,080  Xanthine oxidase inhibitor
0,020  0,015  Retinoic acid alpha receptor antagonist
0,068  0,063  Topoisomerase II alpha inhibitor
0,080  0,076  Potassium channel (Ca-activated) activator
0,056  0,054  Prostaglandin F2 alpha antagonist
0,017  0,015  Retinoic acid receptor antagonist
0,019  0,017  Retinoid X beta receptor agonist
0,006  0,004  Transcortin receptor antagonist
0,124  0,123  Dual specificity phosphatase 3 inhibitor
0,029  0,027  Estrogen receptor alpha agonist
0,018  0,018  Retinoic acid beta receptor agonist

